Clinical Observations on the Association Between Diagnosis of Lung Cancer and Serum Tumor Markers in Combination |
Wang, Wen-Jing
(Department of Infectious Diseases, Nanjing First Hospital, Nanjing Medical University)
Tao, Zhen (Department of Infectious Diseases, Nanjing First Hospital, Nanjing Medical University) Gu, Wei (Department of Respiration, Nanjing First Hospital, Nanjing Medical University) Sun, Li-Hua (Department of Respiration, Nanjing First Hospital, Nanjing Medical University) |
1 | Ardizzoni A, Cafferate MA, Tiseo M, et al (2006). Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer. Cancer, 107, 2842-9. DOI ScienceOn |
2 | Bilgin E, Dizdar Y, Serilmez M, et al (2013). For which cancer types can neuron-specific enolase be clinically helpful in Turkish patients? Asian Pac J Cancer Prev, 14, 2541-4. DOI ScienceOn |
3 | Buccheri G, Eerrigno D (2002). Lung tumor markers in oncology practice: a study of TPA and CA125. Br J Cancer, 87, 1112-8. DOI ScienceOn |
4 | Cho JY, Sung HJ (2009). Proteomic approaches in lung cancer biomarker development. Expert Rev Proteomics, 6, 27-42. DOI ScienceOn |
5 | Fletcher CD, Berman JJ, Corless C, et al (2002). Diagnosis of gastrointestinal stromal tumoes: a consensus approach. Hum Patnol, 33, 459-65. DOI ScienceOn |
6 | Hu LA, Fu Y, Zhang DN, et al (2013). Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer. Asian Pac J Cancer Prev, 14, 2563-6. DOI ScienceOn |
7 | Kav S, Tokdemir G, Tasdemir R, et al (2012). Patients with cancer and their relatives beliefs, information needs and information-seeking behavior about cancer and treatment. Asian Pac J Cancer Prev, 13, 6027-32. DOI ScienceOn |
8 | Liu YC, Zhou SB, Gao F, et al (2013). Chemotherapy and late course three dimensional conformal radiotherapy for treatment of patients with Stage III non-small cell lung cancer. Asian Pac J Cancer Prev, 14, 2663-5. DOI ScienceOn |
9 | Lu YY, Huang XE, Xu L, et al (2013). Potential predictors of sensitivity to pemetrexed as first-line chemotherapy for patients with advanced non-squamous NSCLCs. Asian Pac J Cancer Prev, 14, 2005-8. DOI ScienceOn |
10 | Malik PS, Sharma MC, Mohanti BK, et al (2013). Clinicopathological profile of lung cancer at AIIMS: a changing paradigm in India. Asian Pac J Cancer Prev, 14, 489-94. DOI ScienceOn |
11 | Oguz A, Unal D, Tasdemir A, et al (2013). Lack of any association between blood groups and lung cancer, independent of histology. Asian Pac J Cancer Prev, 14, 453-6. DOI ScienceOn |
12 | Pan JB, Hou YH, Zhang GJ (2013). Correlation between EGFR mutations and serum tumor markers in lung adenocarcinoma patients. Asian Pac J Cancer Prev, 14, 695-700. DOI ScienceOn |
13 | Parkin DM, Brary FB, Pisani P (2005). Global cancer statistics. Cancer J Clin, 55, 74-108. DOI ScienceOn |
14 | Ramshankar V, Krishnamurthy A (2013). Lung cancer detection by screening - presenting circulating miRNAs as a promising next generation biomarker breakthrough. Asian Pac J Cancer Prev, 14, 2167-72. DOI ScienceOn |
15 | Schneider J, Bitterlich N, Velcovsky HG, et al (2002). Fuzzy logic based tumor marker profiles improved sensitivity in the diagnosis of lung cancer. Int J Clin Oncol, 7, 145-51. DOI |